α-Melanocyte Stimulating Hormone in the Modulation of Host Reactions

Endocrine Reviews

Volumn 14, Issue 5, 1993, Pages 564-576

  Catania, Anna ^a   Lipton, James M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; HORMONE RECEPTOR;

BEHAVIOR; FEVER; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; PIGMENTATION; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION;

ACUTE-PHASE REACTION; ALPHA-MSH; ANIMAL; CYTOKINES; FEVER; GENE EXPRESSION; HUMAN; INFLAMMATION; PRO-OPIOMELANOCORTIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION;

EID: 0027330979     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-14-5-564     Document Type: Article

References (151)

1. Eberle AN 1988 The Melanotropins. Karger, Basel, pp 1-556
2. Lipton JM 1988 MSH in CNS control of fever and its influence on inflammation/immune responses. In: Hadley M (ed) The Melano-tropic Peptides. CRC Press, Boca Raton, FL, pp 97-113
3. Lipton JM 1989 Neuropeptide a-melanocyte-stimulating hormone in control of fever, the acute phase response, and inflammation. In: Goetzel E (ed) Neuroimmune Networks: Physiology and Diseases. Alan R. Liss, New York, pp 243-250
4. Lipton JM 1990 Modulation of host defense by the neuropeptide a-MSH. Yale J Biol Med 63:173-182
5. Lipton JM, Catania A 1992 a-MSH peptides modulate fever and inflammation. In: Bartfai T (ed) Proceedings of the International Wenner-Gren Center Symposium on Neuroimmunology of Fever. Pergamon Press, New York, pp 123-136
6. Catania A, Lipton JM 1993 a-MSH peptides in host responses: from basic evidence to human research. Ann NY Acad Sci 680:412-423
7. Lipton JM, Catania A, Pyrogenic and inflammatory actions of cytokines and their modulation by neuropeptides: techniques and interpretations. Methods Neurosci, in press
8. Autelitano DJ, Lundblad JR, Blum M, Roberts JL 1989 Hormonal regulation of POMC gene expression. Annu Rev Physiol 51:715-726
9. Mechanick JI, Levin N, Roberts JL, Autelitano DJ 1992 Proopiomelanocortin gene expression in a distinct population of rat spleen and lung leukocytes. Endocrinology 131:518-525
10. Autelitano DJ, Blum M, Lopingco M, Allen RG, Roberts JL 1990 Corticotropin-releasing factor differentially regulates anterior and intermediate pituitary lobe proopiomelanocortin gene transcription, nuclear precursor RNA and mature mRNA in vivo. Neuroendocrinology 51:123-130
11. Hollt V, Haarmann I 1984 Corticotropin-releasing factor differentially regulates proopiomelanocortin messenger ribonucleic acid in anterior as compared to intermediate pituitary lobes of rats. Biochem Biophys Res Commun 124:407-415
12. Loh YP 1987 Peptide precursor processing enzymes within secretory vesicles. Ann NY Acad Sci 493:292-306
13. Benjannet S, Rondeau N, Day R, Chrétien M, Sedah NG 1991 PCI and PC2 are protein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 88:3564-3568
14. Smith AI, Funder JW 1988 Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9:159-179
15. Dores RM, Jain M, Akil H 1986 Characterization of /3-endorphin and a-MSH in the caudal medulla of the rat and guinea pig. Brain Res 377:251-260
16. Millington WR, O’Donohue TL, Chappel MC, Roberts JL, Mueller GP 1986 Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary. Endocrinology 118:2024-2033
17. Usategui R, Oliver C, Vaudry H, Lombardi G, Rozemberg I, Mourre AM 1976 Immunoreactive a-MSH and ACTH levels in rat plasma and pituitary. Endocrinology 98:189-196
18. Coates PJ, Doniach I, Hale AC, Rees LH 1986 The distribution of immunoreactive a-melanocyte-stimulating hormone cells in the adult human pituitary gland. J Endocrinol 11:335-342
19. Visser M, Swaab DF 1979 Life span changes in the presence of a-melanocyte-stimulating-hormone-containing cells in the human pituitary. J Dev Physiol 1:161-178
20. Civelli O, Birnberg N, Herbert E 1982 Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissue from different species. J Biol Chem 257:6783-6787
21. Bloch B, Bugnon C, Fellmann D, Lenys D, Gouget A 1979 Neurons of the rat hypothalamus reactive with antisera against endorphins, ACTH, MSH and /3-LPH. Cell Tissue Res 204:1-15
22. Gee CE, Chen CC, Roberts JL, Thompson R, Watson SJ 1983 Identification of pro-opiomelanocortin neurons in rat hypothalamus by in situ cDNA-mRNA hybridisation. Nature 306:374-376
23. Larsson LI 1980 Corticotropin and a-melanotropin in brain nerves: immunocytochemical evidence for axonal transport and processing. In: Costa E, Trabucchi M (eds) Neural Peptides and Neuronal Communications. Raven Press, New York, pp 101-107
24. Guy J, Leclerc R, Vaudry H, Pelletier G 1980 Identification of a second category of a-melanocyte stimulating hormone (a-MSH) neurons in the rat hypothalamus. Brain Res 199:135-146
25. O’Donohue TL, Charlton CG, Helke CJ, Miller RL, Jacobowitz DM 1979 Identification of a-melanocyte stimulating hormone immunoreactivity in rat and human brain and cerebrospinal fluid. In: Gross E, Meienhofer J (eds) Peptides, Structure and Biological Function. Pierce Chemical Company, Rockford, IL, pp 897-900
26. Désy L, Pelletier G 1978 Immunohistochemical localization of a-melanocyte stimulating hormone (a-MSH) in the human hypothalamus. Brain Res 154:377-381
27. Arai H, Morji T, Kosaka K, Iizuka R 1986 Extrahypophyseal distribution of a-melanocyte stimulating hormone (a-MSH)-like immunoreactivity in postmortem brains from normal subjects and Alzheimer type dementia patients. Brain Res 377:305-310
28. Parker CR, Barnea A, Tilders FJH, Porter JC 1981 Characterization of immunoreactive a-melanocyte stimulating hormone in human brain tissue. Brain Res Bull 6:275-280
29. Candy JM, Perry RH, Thompson JE, Johnson M, Oakley AE 1985 Neuropeptide localization in the substantia innominata and adjacent regions of the human brain. J Anat 140:309-327
30. Rudman D, Del Rio AE, Hollins BM, Houser DH, Keling ME, Sutin J, Scott JW, Sears RA, Rosenberg MZ 1973 Melanotropic-lipolytic peptides in various regions of bovine, simian and human brains and in simian and human cerebrospinal fluids. Endocrinology 72:372-379
31. Rudman D, Del Rio AE, Chawla RK, Houser DH, Sheen S 1974 An antimelanotropic protein in human cerebrospinal fluid. Am J Physiol 226:693-697
32. Scimonelli T, Eberle AN 1987 Photoaffinity labelling of melanoma cell MSH receptors. FEBS Lett 226:134-138
33. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD 1992 The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-1251
34. Thody AJ, Ridley K, Penny RJ, Chalmers R, Fisher C, Shuster S 1983 MSH peptides are present in mammalian skin. Peptides 4:813-816
35. Fox JAET, Kraicer J 1981 Immunoreactive a-melanocyte stimulating hormone, its distribution in the gastrointestinal tract of intact and hypophysectomized rats. Life Sci 28:2127-2132
36. Clark D, Thody AJ, Shuster S, Bowers H 1978 Immunoreactive a-MSH in human plasma in pregnancy. Nature 163-164
37. Bardin CW, Chen CLC, Morris PL, Gerendai I, Boitani C, Liotta AS, Margioris A, Krieger DT 1987 Proopiomelanocortin-derived peptides in testis, ovary, and tissues of reproduction. Recent Prog Horm Res 43:1-28
38. Evans CJ, Erdelyi E, Weber E, Barchas JD 1983 Identification of pro-opiomelanocortin-derived peptides in the human adrenal medulla. Science 221:957-960
39. Lamacz M, Tonon MC, Louiset E, Cazin L, Vaudry H 1991 The intermediate lobe of the pituitary, model of neuroendocrine communication. Arch Int Physiol Biochim 99:205-219
40. Chen CL, Dionne FT, Roberts JL 1983 Regulation of pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds. Proc Natl Acad Sci USA 80:2211-2215
41. Lookingland KJ, Gunnet JW, Moore KE 1991 Stress-induced secretion of a-melanocyte-stimulating hormone is accompanied by a decrease in the activity of tuberohypophysial dopaminergic neurons. Neuroendocrinology 53:91-96
42. Tiligada E, Wilson JF 1989 D2-but not Dl-dopamine receptors are involved in the inhibitory control of a-melanocyte-stimulating hormone release from the rat hypothalamus. Exp Brain Res 74:645-648
43. Lindley SE, Lookinland KJ, Moore KE 1990 Activation of tuber-oinfundibular but not tuberohypophysial dopaminergic neurons following intracerebroventricular administration of alpha-melanocyte-stimulating hormone. Neuroendocrinology 51:394-9
44. Mabley J, Wayman CP, Wilson JF 1991 Endogenous 7-amino-butyric acid tonically inhibits release of a-melanocyte-stimulating hormone from rat hypothalamic slices. Eur J Pharmacol 209:127-129
45. Carr JA, Saland LC, Samora A, Benavidez S, Krobert K 1991 In vivo effects of serotonergic agents on a-melanocyte-stimulating hormone secretion. Neuroendocrinology 54:616-622
46. Manzanares J, Lookingland KJ, Moore KE 1990 Kappa-opioid-receptor-mediated regulation of a-melanocyte-stimulating hormone secretion and tuberohypophyseal dopaminergic neuronal activity. Neuroendocrinology 52:200-205
47. Berkenbosch F, Vermes I, Tilders FJH 1984 The /3-adrenorecep-tor-blocking drug propranolol prevents secretion of immunoreactive (8-endorphin and a-melanocyte-stimulating hormone in response to certain stress stimuli. Endocrinology 115:1051-1059
48. Knigge U, Warberg J 1991 The role of histamine in the neuroendocrine regulation of pituitary hormone secretion. Acta Endocrinol (Copenh) 124:609-619
49. Van Oers JW, Tilders JH, Berkenbosch F 1989 Characterization and biological activity of a rat monoclonal antibody to rat/human corticotropin-releasing factor. Endocrinology 124:1239-1246
50. Catania A, Martin LW, Lipton JM 1991 Dexamethasone facilitates a-MSH release in the rabbit. Brain Res Bull 26:727-730
51. Tatro JB, Reichlin S 1987 Specific receptors for a-melanocyte stimulating hormone are widely distributed in the tisues of rodents. Endocrinology 121:1900-1907
52. Chhajilani V, Wikberg JES 1992 Molecular cloning and expression of the human melanocyte stimulating hormone cDNA. FEBS Lett 309:417-420
53. Kameyama K, Tanaka S, Ishida Y, Hearing V 1989 Interferons modulate the expression of hormone receptors on the surface of murine melanoma cells. J Clin Invest 83:213-221
54. Tatro JB 1990 Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and alpha-melanocyte stimulating hormone. Brain Res 536:124-132
55. Tatro JB 1993 Brain receptors for central and peripheral melanotropins. Ann NY Acad Sci 680:621-625
56. Clark WG 1991 Antipyretics. In: Mackowiak PA (ed) Fever: Basic Mechanisms and Management. Raven Press, New York, pp 297-340
57. Kluger MJ 1991 Fever: role of endogenous pyrogens and cryogens. Physiol Rev 71:93-127
58. Glyn JR, Lipton JM 1981 Hypothermic and antipyretic effects of centrally administered ACTH(l-24) and a-melanotropin. Peptides 2:177-187
59. Lipton JM, Glyn JR, Zimmer JA 1981 ACTH and a-melanotropin in central temperature control. Fed Proc 40:2760-2762
60. Lipton JM, Glyn-Ballinger JR, Murphy MT, Zimmer JA, Bernardini G, Samson WK 1984 The central neuropeptides ACTH and a-MSH in fever control. J Thermal Biol 9:139-143
61. Zimmer JA, Lipton JM 1981 Central and peripheral injections of ACTH (1-24) reduce fever in adrenalectomized rabbits. Peptides 2:419-423
62. Richards DB, Lipton JM 1984 Antipyretic doses of a-MSH do not alter afebrile body temperature in the cold. J Thermal Biol 9:299-301
63. Murphy MT, Richards DB, Lipton JM 1983 Antipyretic potency of centrally administered a-melanocyte stimulating hormone. Science 221:192-193
64. Murphy MT, Lipton JM 1982 Peripheral administration of a-MSH reduces fever in older and younger rabbits. Peptides 3:775-779
65. Holdeman M, Lipton JM 1985 Antipyretic activity of a potent a-MSH analog. Peptides 6:273-275
66. Martin LW, Lipton JM 1990 Acute phase response to endotoxin: rise in plasma a-MSH and effects of a-MSH injection. Am J Physiol 259:R768-R772
67. 2 in the rabbit. J Physiol 451:491-502
68. Opp MR, Obal F, Kreuger JM 1988 Effects of a-MSH on sleep, behavior, and brain temperature: interactions with IL-1. Am J Physiol 255:R914-R922
69. Hori T, Nakashima T, Take S, Kaizuka A, Mori T, Katafuchi T 1991 Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 27:309-313
70. Martin LW, Catania A, Hiltz A, Lipton JM 1991 Neuropeptide a-MSH antagonizes IL-6-and TNF-induced fever. Peptides 12:297-299
71. Robertson B, Dostal K, Daynes R 1988 Neuropeptide regulation of inflammatory and immunologic responses. J Immunol 140:4300-4307
72. Richards DB, Lipton JM 1984 Effect of a-MSH(ll-13) (lysine-proline-valine) on fever in the rabbit. Peptides 5:815-817
73. Deeter LB, Martin LW, Lipton JM 1989 Antipyretic properties of centrally administered a-MSH fragments in the rabbit. Peptides 9:1285-1288
74. Robertson BA, Gahring LC, Daynes RA 1986 Neuropeptide regulation of interleukin-1 activities. Capacity of a-melanocyte stimulating hormone to inhibit interleukin-1 inducible responses in vivo and in vitro exhibits target cell selectivity. Inflammation 10:371-385
75. Daynes RA, Robertson BA, Cho B-H, Burnam DK, Newton R 1987 a-Melanocyte stimulating hormone exhibits target cell selectivity in its capacity to affect interleukin-1-inducible responses in vivo and in vitro. J Immunol 139:103-109
76. Martin SA, Malkinson TJ, Veale WL, Pittman QJ 1990 Depletion of brain a-MSH alters prostaglandin and interleukin fever in rats. Brain Res 526:351-354
77. Kandasamy SB, Williams BA 1984 Hypothermic and antipyretic effects of ACTH(l-24) and a-melanotropin in guinea pigs. Neuropharmacology 23:49-53
78. Shih ST, Lipton JM 1985 Intravenous a-MSH reduces fever in squirrel monkeys. Peptides 6:685-687
79. Rezvani AH, Denbow DM, Myers RD 1986 Alpha-melanocyte-stimulating hormone infused ICV fails to affect body temperature or endotoxin fever. Brain Res Bull 16:99-105
80. Wunderlich CA 1871 On the Temperature in Diseases: A Manual of Medical Thermometry. New Sydenham Society, London, p 468
81. Lipton JM, Ticknor CB 1979 Influence of sex and age on febrile responses to peripheral and central administration of pyrogens in the rabbit. J Physiol 295:263-272
82. Clark SM, Gean JT, Lipton JM 1980 Reduced febrile responses to peripheral and central administration in aged squirrel monkeys. Neurobiol Aging 1:175-180
83. Tocco-Bradley R, Gluger MJ, Kauffman CA 1985 Effect of age on the febrile response of rat to endotoxin and Salmonella typhi-murium. Infect Immun 47:106-111
84. Norman DC, Yamamura RH, Yoshikawa TT 1988 Fever response in old and young mice after injection of interleukin-1. J Gerontol 43:M80-M85
85. Lipton JM, Murphy MT 1983 Aging enhances the antipyretic effect of a-MSH and the hyperthermic effect of central β-endorphin. In: Lomax P, Schonbaum E (eds) Environment, Drugs and Thermoregulation. Karger, Basel, pp 104-107
86. Murphy MT, Lipton JM 1983 β-Endorphin: effect on thermoregulation in aged monkeys. Neurobiol Aging 4:187-190
87. Dao TK, Bell RC, Feng J, Jameson DM, Lipton JM 1988 C-reactive protein, leukocytes, and fever after central IL-1 and a-MSH in aged rabbits. Am J Physiol 254:R401-R409
88. Miller D, Yoshikawa T, Castle SC, Norman D 1991 Effect of age on fever response to recombinant tumor necrosis factor alpha in a murine model. J Gerontol 5:M176-179
89. Bell RC, Lipton JM 1987 Concentration of melanocyte stimulating hormone (MSH) within specific brain regions in aged squirrel monkeys. Brain Res Bull 18:577-579
90. Deeter LB, Martin LW, Lipton JM 1989 Repeated central administration of a-MSH does not alter the antipyretic effect of a-MSH in young and aged rabbits. Peptides 10:697-699
91. Samson WK, Lipton JM, Zimmer JA 1981 The effect of fever on central a-MSH concentrations in the rabbit. Peptides 2:419-423
92. Holdeman M, Khorram O, Samson WK, Lipton JM 1985 Fever specific changes in MSH and CRF concentrations. Am J Physiol 248:R125-R129
93. Bell RC, Lipton JM 1987 Pulsatile release of antipyretic neuropeptide a-MSH from septum of rabbit during fever. Am J Physiol 252:R1152-R1157
94. Glyn-Ballinger JR, Bernardini GL, Lipton JM 1983 a-MSH injected into the septal region reduces fever in rabbits. Peptides 4:199-203
95. Shih ST, Khorram O, Lipton JM, McCann SM 1986 Central administration of a-MSH antiserum augments fever in the rabbit. Am J Physiol 250:R803-R806
96. Martin LW, Deeter LB, Lipton JM 1989 Acute phase response to endogenous pyrogen in rabbit: effects of age and route of administration. Am J Physiol 257:R189-R193
97. Catania A, Suffredini AF, Lipton JM 1991 a-MSH response to endotoxin in normal human subjects. FASEB J 5:A1392
98. Kitchen EA, Dawson W, Rainsford K, Cawston T 1985 Inflammation and possible modes of action of anti-inflammatory drugs. In: Rainsford KD (ed) Antiinflamatory and Anti-rheumatic Drugs. CRC Press, Boca Raton, FL, vol 1:21-87
99. Movat HZ 1985 The Inflammatory Reaction. Elsevier, Amsterdam, pp 1-365
100. Falus A, Meretey K 1992 Histamine: an early messenger in inflammatory and immune reactions. Immunol Today 13:154-156
101. Hiltz ME, Lipton JM 1989 Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide a-MSH. FASEB J 3:2282-2284
102. Hiltz ME, Lipton JM 1990 Alpha-MSH peptides inhibit acute inflammation and contact hypersensitivity. Peptides 11:979-982
103. Rheins LA, Cotleur AL, Kleier RS, Hoppen j ans WB, Saunder DN, Nordlund JJ 1989 a-Melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Invest Dermatol 93:511-517
104. Hiltz ME, Catania A, Lipton JM 1991 Antiinflammatory activity of a-MSH(ll-13) analogs: influences of alterations in stereochemistry. Peptides 12:767-771
105. Hiltz ME, Catania A, Lipton JM 1992 a-MSH peptides inhibit acute inflammation induced in mice by rIL-lb, rIL-6, rTNFa and endogenous pyrogen but not that caused by LTB4, PAF and rlL-Cytokine 4:320-328
106. Camussi G, Tetta C, Bursolino F, Baglioni C 1989 Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Eur J Biochem 182:661-666
107. Camussi G, Tetta C, Baglioni C 1990 The role of platelet-activating factors in inflammation. Clin Immunol Immunopathol 57:331-338
108. Thomsen MK, Larsen CG, Thomsen HK, Kirstein D, Skak-Nielsen T, Ahnfelt-Ronne I, Thestrup-Pedersen K 1991 Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis. J Invest Dermatol 96:260-266
109. Dinarello CA 1989 Was the original endogenous pyrogen interleukin-1? In: Bomford C, Henderson C (eds) Interleukin-1, Inflammation and Disease. Elsevier Science Publishers, New York, pp 17-28
110. Lipton JM, Macaluso A, Hiltz ME, Catania A 1991 Central administration of the peptide a-MSH inhibits inflammation in the skin. Peptides 12:795-798
111. Dulaney R, Macaluso A, Woerner J, Hiltz M, Catania A, Lipton JM 1992 Changes in peripheral inflammation induced by CNS actions of an a-MSH analog and of endogenous pyrogen. Prog Neuroendocrinimmunol 5:179-186
112. Catania A, Arnold J, Macaluso A, Hiltz ME, Lipton JM 1991 Inhibition of acute inflammation in the periphery by central action of salicylates. Proc Natl Acad Sci USA 88:8544-8547
113. Coderre TJ, Bausbam A, Levine JD 1989 Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents. J Neurophysiol 62:48-58
114. Beeson JM, Chaouch A 1987 Peripheral and spinal mechanisms of nociception. Physiol Rev 67:67-186
115. Cannon JG, Tatro JB, Reichlin S, Dinarello CA 1986 Melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137:2232-2236
116. Mason MJ, Van Epps D 1989 Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by a-me-lanocyte-stimulating hormone. J Immunol 142:1646-1651
117. Sundar SK, Becker KJ, Cierpial MA, Carpenter MD, Rankin LA, Fleener SL, Ritchie JC, Simson PE, Weiss JM 1989 Intracerebro-ventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc Natl Acad Sci USA 86:6398-6402
118. Sundar SK, Cierpial MA, Kiltz C, Ritchie JC, Weiss JM 1991 Effects of interleukin-1 infused into brain are antagonized by a a-MSH in a dose-dependent manner. Eur J Pharmacol 192:177-179
119. Sundar SK, Cierpial MA, Kamaraju LS, Long S, Hsieh S, Lorenz C, Aaron M, Ritchie JC, Weiss JM 1991 Human immunodeficiency virus glycoprotein (gpl20) infused into rat brain induces interleukin-1 to elevate pituitary-adrenal activity and decreases peripheral cellular immune responses. Proc Natl Acad Sci USA 88:11246-11250
120. Saperstein A, Brand H, Audhya T, Nabriski D, Hutchinson B, Rosenzweig S, Hollander CS 1992 Interleukin 1 beta mediates stress-induced immunosuppression via corticotropin-releasing factor. Endocrinology 130:152-158
121. Lyson K, McCann SM, Alpha-melanocyte-stimulating hormone abolishes IL-1-, IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology, in press
122. Shalts E, Feng Y-J, Ferin M, Wardlaw SL 1992 a-Melanocyte-stimulating hormone antagonizes the neuroendocrine effects of corticotropin-releasing factor and interleukin-la in the primate. Endocrinology 131:132-138
123. Uehara Y, Shimizu H, Sato N, Tanaka Y, Shimomura Y, Mori M 1992 Carboxyl-terminal tripeptide of alpha-melanocyte-stimulating hormone antagonizes interleukin-1-induced anorexia. Eur J Pharmacol 220:119-122
124. Poole S, Bristow AF, Lorenzetti BB, Gaines RE, Smith TW, Ferreira SH 1992 Peripheral analgesic activities of peptides related to a-melanocyte stimulating hormone and interleukin-1/3193-195. Br J Pharmacol 106:489-492
125. Folienfant RL, Nakamura CM, Henderson B, Higgs GA 1989 Inhibition by neuropeptides of interleukin-1/3 induced, prostaglandin-independent hyperalgesia. Br J Pharmacol 98:41-43
126. Mugridge KG, Peretti M, Gheara P, Parente L 1991 a-Melano-cyte-stimulating hormone reduces interleukin-1/3 effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 197:151-155
127. Taylor AW, Streilein JW, Cousins SW 1992 Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 11:1199-1206
128. Taylor AW, Streilein JW, Cousins SW 1993 Alpha-melanocyte stimulating hormone inhibits IFN-y-dependent T-cell and macrophage participation in immunogenic inflammation. J Immunol 150:129A
129. Bull DF, King MG, Pfister HP, Singer G 1990 Alpha-melanocyte-stimulating hormone conditioned suppression of a lipopolysaccha-ride-induced fever. Peptides 11:1027-1031
130. Strand FL, Rose KJ, King JA, Segarra AC, Zuccarelli LA, 1989 ACTH modulation of nerve development and regeneration. Prog Neurobiol 33:45-85
131. Strand FL, Rose KJ, Zuccarelli LA, Kume J, Alves SE, Antona-wich FJ, Garret LY 1991 Neuropeptide hormones as neurotrophic factors. Physiol Rev 71:1017-1046
132. Swaab DF, Boer GJ, Visser M 1978 The fetal brain and intrauterine growth. Postgrad Med J 57 [Suppl 1]:63-73
133. 7]alpha-MSH improves functional recovery in rats subjected to diencephalic hemisection. Eur J Pharmacol 150:211-219
134. 7)a-MSH: a central effect. Neuropeptides 11:137-142
135. Wolterink G, Van Zanten E, Van Ree JM 1990 Functional recovery after destruction of dopamine systems in the nucleus accum-bens of rats. IV. Delay by intra-accumbal treatment with ORG 2766-or a-MSH antiserum. Brain Res 507:115-120
136. Wolterink G, Van Ree JM 1990 Functional recovery after destruction of dopamine systems in the nucleus accumbens of rats. III. Further analysis of the facilitating effect of the ACTH-(4-9) analog ORG 2766. Brain Res 507:109-114
137. Jimenez M, Kameyama K, Maloy WL, Hearing VJ 1988 Mammalian tyrosinase biosynthesis, processing and modulation by melanocyte stimulating hormone. Proc Natl Acad Sci USA 85:3830-3834
138. Kwon BS, Wakulchik M, Haq AK, Halaban R, Kestler D 1988 Sequence analysis of mouse thyrosinase cDNA and the effect of melanotropin on its gene expression. Biochem Biophys Res Commun 153:1301-1309
139. Hearing V, Tsukamoto K 1991 Enzymatic control of pigmentation in mammals. FASEB J 5:2902-2909
140. Levine N, Sheftel SN, Eytan T, Dorr RT, Hadley ME, Weinrach JC, Ertl GA, Toth K, McGee DL, Hruby VJ 1991 Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA 266:2730-2736
141. Gallais V, Lacour JP, Perrin C, Ghanem G, Bodokh I, Ortonne JP 1992 Acral hyperpigmented macules and longitudinal melan-onchya in AIDS patients. Br J Dermatol 126:387-391
142. Pears JS, Jung RT, Bartlett W, Browning MC, Kenicer K, Thody AJ 1992 A case of skin hyperpigmentation due to alpha-MSH hypersecretion. Br J Dermatol 126:286-289
143. Lerner AB, McGuire JS 1961 Effect of a-and N-melanocyte stimulating hormones on the skin colour of man. Nature 189:176-179
144. Thody AJ, Fisher C, Kendal-Taylor P, Jones MT, Price J, Abraham RR 1985 The measurement and characterisation by high pressure liquid chromatography of immunoreactive a-melanocyte stimulating hormone in human plasma. Acta Endocrinol (Copenh) 110:313-318
145. Abraham RR, Campbell EA, Gillham B, Thody AJ, Altaher ARH, Prysor Jones A, Wynn V, Jones MT, Jenkins J 1986 The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine, and TRH on the secretion of ACTH and a-MSH in Nelson’s syndrome and Cushing’s disease. Clin Endocrinol (Oxf) 25:75-85
146. Coates PJ, McNicol AM, Doniach I, Rees LH 1988 Increased production of a-melanocyte stimulating hormone in the pituitary of patients with untreated Addison’s disease. Clin Endocrinol (Oxf) 29:421-426
147. Ghanem G, Lienard D, Hanson P, Lejeune F, Früling J 1986 Increased serum a-melanocyte stimulating hormone (a-MSH) in human malignant melanoma. Eur Cancer Clin Oncol 22:535-536
148. Kastin AJ, Hawley WD, Miller MC, Schally AV, Lancaster C 1974 Plasma MSH and cortisol levels in 567 patients with special reference to brain trauma. Endocrinol Exp 8:97-105
149. Rainero I, May C, Kaye JA, Friedland RP, Rapoport SI 1988 CSF a-MSH in dementia of the Alzheimer type. Neurology 38:1281-1284
150. Rainero I, Kaye JA, May C, Durso R, Katz DI, Albert ML, Wolfe N, Pinessi L, Friedland RP, Rapoport SI 1988 a-Melanocyte-stimulating hormone-like immunoreactivity is increased in patients with Parkinson’s disease. Arch Neurol 45:1224-1227
151. Catania A, Airaghi L, Manfredi MG, Vivirito MC, Milazzo F, Lipton JM, Zanussi C 1993 Proopiomelanocortin-derived peptides and cytokines:relations in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 66:73-79